MACROGENICS INC — Director's Dealing 2024

Feb 7, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2024-02-05

Reporting Person: Peters Jeffrey Stuart (Senior VP and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-05	Common Stock	M	54376	$11.50	Acquired	54376	Direct
2024-02-05	Common Stock	M	21875	$10.15	Acquired	76251	Direct
2024-02-05	Common Stock	S	54376	$16.50	Disposed	21875	Direct
2024-02-05	Common Stock	S	21875	$16.50	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-05	Employee stock option (right to buy)	$11.50	M	54376	Disposed	2030-02-20	Common Stock (54376)	Direct
2024-02-05	Employee stock option (right to buy)	$10.15	M	21875	Disposed	2032-02-22	Common Stock (21875)	Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 11/10/2022.

F2: 12.5% of the shares underlying the grant became exercisable 6 months after the date of grant and an additional 6.25% of the shares underlying the grant became exercisable on the first day of each three-month period thereafter.